Article Versions Notes

Lin GC, Küng E, Smajlhodzic M, Domazet S, Friedl HP, Angerer J, Wisgrill L, Berger A, Bingle L, Peham JR, et al. Directed Transport of CRP Across In Vitro Models of the Blood-Saliva Barrier Strengthens the Feasibility of Salivary CRP as Biomarker for Neonatal Sepsis. Pharmaceutics. 2021; 13(2):256. https://doi.org/10.3390/pharmaceutics13020256

Lin, Grace C., Erik Küng, Merima Smajlhodzic, Sandra Domazet, Heinz P. Friedl, Joachim Angerer, Lukas Wisgrill, Angelika Berger, Lynne Bingle, Johannes R. Peham, and et al. 2021. "Directed Transport of CRP Across In Vitro Models of the Blood-Saliva Barrier Strengthens the Feasibility of Salivary CRP as Biomarker for Neonatal Sepsis" Pharmaceutics 13, no. 2: 256. https://doi.org/10.3390/pharmaceutics13020256

Lin, G. C., Küng, E., Smajlhodzic, M., Domazet, S., Friedl, H. P., Angerer, J., Wisgrill, L., Berger, A., Bingle, L., Peham, J. R., & Neuhaus, W. (2021). Directed Transport of CRP Across In Vitro Models of the Blood-Saliva Barrier Strengthens the Feasibility of Salivary CRP as Biomarker for Neonatal Sepsis. Pharmaceutics, 13(2), 256. https://doi.org/10.3390/pharmaceutics13020256